Effect of arterial hypertension on chronic urticaria duration

Annals of Allergy, Asthma and Immunology

Volumn 103, Issue 5, 2009, Pages 407-410

  Nebiolo, Franco ^a   Bergia, Roberta ^a   Bommarito, Luisa ^a   Bugiani, Massimiliano ^b   Heffler, Enrico ^a   Carosso, Aurelia ^b   Castiglioni, Gloria ^b   Guida, Giuseppe ^a   Badiu, Iuliana ^a   Pizzimenti, Stefano ^a   Mietta, Sabrina ^a   Ferrero, Nicoletta ^a   Rolla, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b ASL TO2   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; ANTINUCLEAR ANTIBODY; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN E; METHYLPREDNISOLONE; THYROID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; ATOPY; AUTOIMMUNITY; AUTOLOGOUS SERUM SKIN TEST; BLOOD CLOTTING; CHRONIC IDIOPATHIC URTICARIA; CHRONIC URTICARIA; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HELICOBACTER INFECTION; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATHOGENESIS; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SKIN TEST; CHRONIC DISEASE; DISEASE COURSE; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; URTICARIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HISTAMINE ANTAGONISTS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; URTICARIA;

EID: 73349087837     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60360-2     Document Type: Article

References (30)

1. Sheikh J. Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they? Curr Opin Allergy Clin Immunol. 2005;5:403- 407.
2. Harris A, Twarog FJ, Geha RS. Chronic urticaria in childhood: natural course and etiology. Ann Allergy. 1983;51:161-165.
3. Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol. 2005;5:408-412.
4. Tong LJ, Balakrishnan G, Kochan JP, et al. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99: 461-465.
5. Sabrone RA, Grattan CE, Francis DM, et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. 1999;140:446-452.
6. Fukuda S, Shimoyama T, Umegaki N, et al. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol. 2004;39:827-830.
7. Shiotani A, Miyanishi T, Kamada T, et al. Helicobacter pylori infection and allergic diseases: epidemiological study in Japanese university students. J Gastroenterol Hepatol. 2008;23:29-33.
8. Sibbald RG, Cheema AS, Lozinski A, et al. Chronic urticaria: evaluation of the role of physical, immunologic, and other contributory factors. Int J Dermatol. 1991;30:381-386.
9. Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy. 2004;59:869-873.
10. Breneman D, Bronsky EA, Bruce S, et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebocontrolled, comparative trial. J Am Acad Dermatol. 1995;33:192-198.
11. Kulthanan K, Jiamton S, Thumpimukvatana N, et al. Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol. 2007;34: 294-301.
12. Makris TK, Stavroulakis GA, Krespi PG, et al. Fibrinolytic/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol. Am J Hypertens. 2000;13:783-788.
13. Parslew R, Pryce D, Ashworth J, et al. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy. 2000;30: 1161-1165.
14. Barlow RJ, Greaves MW. Warfarin in the treatment of chronic urticaria/ angio-edema. Br J Dermatol. 1992;126:415- 416.
15. Zuberbier T, Bindslev-Jensen C, Canonica GW, et al. EAACI/ GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy. 2006;61:316 -320.
16. Cox, DR, Oakes D. Analysis of Survival Data. London, England: Chapman & Hall; 1984.
17. Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6: 461-464
18. Collett B. Modelling Survival Data in Medical Research. London, England; Chapman and Hall; 2003.
19. Asero R, Tedeschi A, Coppola R, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol. 2007;119:705-710.
20. Asero R, Tedeschi A, Riboldi P, et al. Severe chronic urticaria is associated with elevated plasma levels of D-dimer. Allergy. 2008;63: 176-180.
21. Szaba FM, Smiley ST. Roles for thrombin and fibrin(ogen) in cytokine/ chemokine production and macrophage adhesion in vivo. Blood. 2002; 99:1053-1059.
22. Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006; 12:682-687.
23. Kikuchi Y, Kaplan APA. role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002;109:114-118.
24. Trifiletti A, Scamardi R, Pizzoleo MA, et al. Increased indexes of thrombin activation in advanced stages of hypertension. Haemostasis. 2001;31:49-54.
25. Malyszko J, Tymcio J. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertension. Pol Arch Med Wewn. 2008;118:36-41.
26. Makris TK, Stavroulakis G, Papadopoulos DP, et al. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan. Drugs Exp Clin Res. 2004;30:125-132.
27. Khaleghi M, Singletary LA, Kondragunta V, et al. Haemostatic markers are associated with measures of vascular disease in adults with hypertension. J Hum Hypertens. 2009;23:530 537.
28. Nagashima J, Musha H, Takada H, et al. Influence of physical fitness and smoking on the coagulation system in hypertensive patients: effect on prothrombin fragment F1+2. Intern Med. 2007;46:933-936.
29. Nadar S, Lip GY. The prothrombotic state in hypertension and the effects of antihypertensive treatment. Curr Pharm Des. 2003;9:1715-1732.
30. Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2. Ann Allergy Asthma Immunol. 2008;100: 517-526.